Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
Beren Therapeutics has raised $165.0M in total funding. The most recent round was Debt Financing. The last funding was announced in June 2026.
Beren Therapeutics's investors include Founders Fund, Gaingels, JIC Venture Growth Investments, Wellington Partners, Narya Capital.
Beren Therapeutics is headquartered in Thousand Oaks, United States.
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
Beren Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beren Therapeutics — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/beren-therapeutics. Accessed November 12, 2026.
VCBacked. (2026). Beren Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/beren-therapeutics
{{cite web |title=Beren Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/beren-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Beren Therapeutics? Request a listing update